Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
PREcision DIagnostics in Prostate Cancer Treatment PREDICT
Study Type: Treatment
Phase: II
NCTID: NCT06632977
Principal Investigator:
Elizabeth Wulff-Burchfield
A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer COMPPARE
A Multi-Center, Randomized, Assessor-Blind, Controlled Trial Comparing the Occurrence of Major Adverse Cardiovascular Events MACEs in Patients with Prostate Cancer and Cardiovascular Disease Receiving Degarelix GnRH Receptor Antagonist or Leuprolide GnRH Receptor Agonist
SpaceIT Hydrogel System for Perirectal Spacing in Subjects with Low to Intermediate Risk Prostate Cancer Undergoing External Beam Radiotherapy EBRT: A multicenter, randomized, controlled clinical study HYDROSPACE
Study Type: Other
Phase: Device
NCTID: NCT06451614
Principal Investigator:
Xinglei Shen
Sleep Hygiene Education, ReadiWatchTM Actigraphy, And Telehealth Cognitive Behavioral Training For Insomnia Effect, On Symptom Relief For Men With Prostate Cancer Receiving Androgen Deprivation Therapy ADT SHERE-Relief 2.
Study Type: Supportive Care
Phase: Feasibility/Pilot
NCTID: NCT05582759
Principal Investigator:
Jamie Myers
A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer with Bone Metastases COMRADE
A Phase II Multiple-Dose, Multiple-Arm, Parallel Assignment Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of XmAb20717 Alone or in Combination with Chemotherapy or Targeted Therapies in Selected Subjects with Metastatic Castration-Resistant Prostate Cancer
A Phase III, Multi-center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA IT PET/CT in Men with Biochemical Recurrence of Prostate Cancer
A Randomized, 2-cohort, Double-blind, Placebo-controlled, Phase III Study of AZD5305 in Combination with Physician?s Choice New Hormonal Agents in Patients with HRRm and non-HRRm Metastatic Castration-Sensitive Prostate Cancer EvoPAR-Prostate01
Study Type: Treatment
Phase: III
NCTID: NCT06120491
Principal Investigator:
Elizabeth Wulff-Burchfield
Increasing the Dose of Survivorship Care Planning in Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy
Study Type: Health Services
Phase: III
NCTID: NCT03860961
Principal Investigator:
Ronald Chen